Re: Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk [3] (multiple letters)

Journal of Urology

Volumn 169, Issue 6, 2003, Pages 2304-2305

  Pruthi, Raj S ^a   Derksen, J Eric ^a   Gaston, Kris ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; FINASTERIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN RECEPTOR BLOCKING AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; DRUG EFFECT; DRUG USE; ENZYME INHIBITION; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0038286461     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000065383.98815.8e     Document Type: Letter

References (2)

1. R.O. Roberts D.J. Jacobson C.J. Girman T. Rhodes M.M. Lieber S.J. Jacobsen A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer Mayo Clin Proc 77 2002 219
2. J.E. Nelson R.E. Harris Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study Oncol Rep 7 2000 169